Mereo BioPharma Group Plc (MREO)
2.25
-0.06
(-2.60%)
USD |
NASDAQ |
Dec 11, 16:00
2.25
0.00 (0.00%)
Pre-Market: 09:24
Mereo BioPharma Group Cash from Investing (Quarterly): 0.3027M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Adaptimmune Therapeutics Plc | 18.84M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0656M |
| Autolus Therapeutics Plc | 35.49M |
| Bicycle Therapeutics Plc | -0.6709M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.256M |
| Cash from Financing (Quarterly) | -0.0014M |
| Free Cash Flow | -33.02M |
| Free Cash Flow Per Share (Quarterly) | -0.0453 |
| Free Cash Flow to Equity (Quarterly) | -7.050M |
| Free Cash Flow to Firm (Quarterly) | -7.228M |
| Free Cash Flow Yield | -9.29% |